MedTech Innovator

CardiaCare is a medical device for with neuromodulation therapy in AFib patients.

52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy.

PopCheck Technologies is an early-stage firm that specializes in remote postoperative monitoring technologies.

Limax Biosciences transform tissue healing inside and outside the body.

Lazurite is a pre-revenue medical device startup company backed by private capital. The company has raised approximately $18 million to date from institutional investors, high-net worth individuals, and more than 50 physician champions. Lazurite has developed novel technology that will enable it to create the operating room of the future. The company’s product pipeline features the ArthroFree™ wireless camera system, the world’s first fully wireless minimally invasive camera system platform designed for the operating room; ORFree™, the world’s first fully wireless mobile minimally invasive surgical camera platform; and others based on the company’s novel and patented Meridiem™ light engine technology.

Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. The company focuses on enhancing cardiac care through innovative technology, providing tools that assist healthcare professionals in identifying potential heart issues. Anumana's platform extends beyond diagnostics, aiming to improve patient outcomes throughout the entire continuum of cardiovascular care, including perioperative and acute settings. By utilizing machine learning techniques, Anumana aims to refine screening processes, making it easier for clinicians to detect heart diseases and intervene promptly. This approach contributes to more efficient healthcare delivery and better management of cardiovascular health.

Aqua Medical developed a vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and prevent GI cancers. The company's ablation technology is consists of high-temperature water vapor created by a radiofrequency generator that delivers endoscopically through proprietary catheters to the GI tract. Aqua Medical was founded in 2016 by Virender K. Sharma and is based in Santa Ana, California, United States.

Augment Health is developing a noninvasive bladder monitor and AI algorithm for 7M patients with bladder dysfunction following neurologic disease or injury, a $12.3B market. The technology shifts in-clinic diagnostics, which today face a 44% inconclusive test rate, to the home while also eliminating reversed bladder filling and rectal catheterization through proprietary data analysis.

TrackX Technology develops a tracking technology that provides real-time virtual live fluoroscopy. It focuses on creating profound procedurally driven imaging solutions that provide priceless benefits to the surgeon, hospital, and entire operating room.

Garwood Medical Devices is a developer of electronic medical devices intended to eliminate infection-causing bacteria on metallic implants without the need for follow-up surgeries, while also allowing patients to retain their implants, enabling medical practitioners to treat implant infections in a better and more effective manner.

Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians.

New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort™ System, a novel surgical imaging and access system for minimally invasive surgery. The company is led by an experienced team of medical device innovators and commercial experts who have come together to design and commercialize impactful solutions that meet a variety of unmet market needs. The company’s proprietary VisionPort™ system combines multiple imaging and access devices into just one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical and economic advantages to minimally invasive surgery operating rooms around the world.

MindMics is an emerging wearable company revolutionizing the information they can understand about the inner workings of our bodies and health. They hears every heartbeat to capture clinically meaningful biometrics accurately within real-time to unleash mental performance.

RevBio is commercializing an injectable, self-setting, osteoconductive bone adhesive biomaterial that can bond bone to bone and bone to metal in a wet field environment. The company's showcase product, Tetranite, is being reviewed by the FDA for a growing body of applications including oral, craniofacial, orthopedic, and neurosurgical indications. Over time, this synthetic adhesive biodegrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.

Healthcare X.0 is an online healthcare platform that provides its clients with digitization solutions. The platform provides its clients with health, vascular, patient, onco, nephro, cardio, wound, tele, patient, and diabetic assist database solutions. Healthcare X.0 was launched in 2013 by and is based in Niedersachsen.

Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

SUTUREGARD Medical is a medical device company that commercializes surgical products that simplify wound closure. Its device closes high-tension wounds without flaps or grafts, simplifying challenging skin wound closure. It also helps in closing fragile skin wounds without tearing the skin which results in less damage to the skin than sutures alone, enabling patients to heal their wounds in a painless procedure.

Discure Technologies is developing a minimally invasive, implantable bioelectronic device designed to treat and reverse degenerative disc disease (DDD), healing the disc, reducing pain, and restoring function to patients.

Leadoptik is a deep-tech company specializing in building a miniature imaging platform. It empowers minimally invasive interventions with 3D navigation capability and high-resolution imaging in real time.

Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Endoluxe’s unique design combines state-of-the-art sophistication with user friendliness, empowering the physician-surgeon with the ability to perform endoscopic procedures in any setting, at any moment, with an integrated suite of software features connected within the cloud.

Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.

MeaCor develops novel transcatheter devices for the treatment of heart disease.

Gravitas Medical is a developer personalized automated nutrition management system for hospital nutrition. The company was founded in 2015 and is headquartered in San Francisco, California.

Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.

Endiatx is a medical device manufacturing company that specializes in developing a series of pill-sized robots to perform remote diagnoses. Its propulsion system allows the pill robots to actively navigate the entire length of the GI tract in approximately 30 minutes with real-time video control.

Ad Vital is the only digital marketing tool practice needs. It helps attract, convert and retain more patients with less work.

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

Phiex Technologies on-demand, interactive materials for efficient and cost-effective medical device manufacturing, food safety and packaging, and innovations for pathogens.

ConKay Medical Systems is an early-stage medical device company advancing solutions to treat valvular regurgitation in patients with progressive heart failure.

EvoEndo develops systems that enable unsedated endoscopic procedures through a combination of sterile single-use, multi-specialty flexible endoscopes; VR-based patient distraction; and a comprehensive software integration platform. Our technology allows pediatric patients and adults alike to receive routine endoscopies in the clinic without the use of general anesthesia or sedation while reducing complexity, cost, and patient/provider apprehension.

Corveus Medical is developing a new way to prevent heart failure. It is a neuromodulation device that can uniquely reach tissues, unlocking a new field of heart failure treatment. Its goal is to develop a device that safely accesses tissue, providing consistent results.

SafeBeat Rx provides software technology that powers Cardiac Therapeutics - All from a Phone.

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions for potential cancer in seconds.

SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life. About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

Woven Orthopedic Technologies is a developer of fabric technologies for the neuro-musculoskeletal industry. It strives to influence advancements in care by treating patients according to their individual needs and ensuring those treatments are widely accessible. The company designs and develops specialized orthopedic solutions to help enhance fixation in patients undergoing procedures that use orthopedic screws. Woven Orthopedic Technologies' premier technology addresses the most commonly used implant in orthopedics and provides a simple, repeatable, and standardized solution for orthopedic surgeons. The company was founded in 2013 and is based in Manchester, Connecticut.

Liquet Medical is a medical device development company that transforms the way the vascular disease is treated through localized drug delivery. The Versus Catheter will be Liquet Medical’s first technology to market.

Tricog Health offers cardiac diagnostic tools to help solve cardiovascular conditions by identifying them in real-time and with accuracy. Tricog's medical-grade AI and intuitive tools improve the cardiac care of patients by solving cardiac care infrastructure, expertise, bandwidth, availability, and efficiency gaps. Tricog is committed to providing virtual cardiac diagnostic tools and services to all healthcare providers, assisting them in making accurate, timely, and consistent diagnoses and providing timely care.

Cari Health develops remote medication monitors that allow clinicians to prescribe medications and receive real-time reporting on medication levels. Its monitors are wireless sensors that are worn on the patient's skin and continuously send data about medication levels to the cloud. The company was founded in 2015, incorporated in 2021 and is headquartered in San Diego, California.

Moon Surgical is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room. The Maestro System from Moon Surgical, provides complete control, fresh trust, and technology that can adapt to every condition faced, resulting in increased operating room efficiency and surgical care for patients. Moon Surgica is employing tomorrow's technology to alter surgery today.

Fluid Biomed is a medical device start-up focused on creating an implantable dissolving stent for the treatment of brain aneurysms. Founded by neurosurgeons, the company aims to improve patient outcomes by providing a device that promotes healing while minimizing the need for invasive procedures.

MicroGEM serves to democratize molecular biology by moving molecular techniques out of skilled laboratories to non-laboratory settings.

Epineuron is a bioelectronic medicine company bringing a new standard of care for peripheral nerve repair and regeneration. The company is developing a suite of surgical solutions for repairing and treating peripheral nerve injuries with the mission of becoming the world leader in bioelectronic nerve care, starting with its neuroregenerative therapy.

LiveMetric is a medical device company developing non-invasive sensing and deep data analytics solutions. The company transforming the care and condition-management of hypertension and cardiovascular diseases. Using their own proprietary, non-invasive arterial pressure technology, they provide a wearable, non-invasive medical device which enables AI-augmented care and condition management treatment services management. LiveMetric delivers high fidelity arterial pressure waveforms and detailed activity mapping of the single user at any time. They seek to empower individuals, payors, self-insured employers and healthcare providers with an accurate, fact-based, personalized care platform that has the potential for improving the care and lives of over 1 Billion people worldwide who suffer from these conditions. The company's goal is to provide prescribed patients, caregivers, and payors with pertinent data and detailed daily activity mapping.

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and development activities aimed at improving the competitiveness of the business.

PyrAmes has developed a paper thin, flexible, ultra low power device for non-invasive monitoring of blood pressure

Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients. Flosonics's flagship smart-bandage product, the FloPatch, addresses unmet clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance, emergency department, operating room, and intensive care unit.

Forest Devices is a medical device startup that develops a novel stroke screening device designed to detect early signs of stokes.

ApiFix minimally invasive scoliosis correction system is aimed to treat patients suffering from Adolescent Idiopathic Scoliosis (AIS) that are classified as Lenke Type 1 or and Type 5, having with a Cobb angle from 35 to 55 degrees. Unlike the traditional scoliosis correction operation that tries attempts to fix the deformity in one aggressive and complex operation, the ApiFix system is based on a minimal surgical intervention and a correction process that spans over several months, with the aid of unique physical therapy.

OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue. OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leading researchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system. With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.

Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape. Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses. Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.

Starling Surgical is working to develop a new revolution in wound closure technology. Their goal is to disrupt the industry of wound closure by delivering a device that provides an optimum wound closure every time.

CloudCath is offering a sensor enabled digital platform for peritoneal dialysis patients that provides early complication detection and safely reduces the number of monthly patient visits.

Artificial Intelligence and Wearables to detect sepsis in the at home care setting.

Altratech Limited designs biosensors and semiconductor chips for DNA testing of food traceability for agri business. The company was incorporated in 2013 and is based in Shannon, Ireland.

Olfactomics is a Finnish university-based spinoff company developing a novel technology for surgical tissue assessment. They focus on improving breast-concerving lumpectomies where residual tumor continues to be an issue. Realtime tissue analysis allows the surgeon to remove the whole tumor in one operation and minimize the resection of healthy tissues.

HEPTA Medical develops a microwave ablation platform for cancer treatment. Our solution features a unique proprietary temperature sensor enabling to control in real-time the ablation volume.

Forest Devices is a medical device startup that develops a novel stroke screening device designed to detect early signs of stokes.

Previvo is a medical device compamy dedicated to preventing genetic disease using our patent-pending technology to facilitate pre-implantation genetic testing.

ABO holds an exclusive license from Northwestern University and Evanston Northwestern Healthcare to multiple pending patents.

ZKR has developed a new medical device and procedure that addresses chronic knee pain caused by the medical condition Condromalacia Patellae, a degeneration of the shock absorption at the knee cap. Millions of people suffer from this condition, which is caused by inflammation of the underside of the patella and softening of the cartilage. Most sufferers postpone medical intervention and suffer with the pain for years as the condition worsens, because until now, the solution is major surgery. Now, physicians can offer a truly effective solution, delivering mobility, relief from pain and possibly even avoiding the need for a knee replacement procedure. Developed by Dr. Jeffrey Halbrecht, a pioneer in minimally invasive techniques in arthroscopic surgery. The company has multiple patents, and has developed prototypes. ZKR is raising capital for product trials.

EPIC Neuro is developing a small, leadless, minimally invasive device that provides brain stimulation and cortical EEG recording for stroke.

Venari Medical’s mission focus is on the innovation of unparalleled safe, effective, patient-centered medical devices that improve quality of life for those with debilitating vascular disease. Venari Medical are developing BioVena™ - a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned to disrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway. Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. Venari Medical offers an unrivaled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment. The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers that currently incur annual costs of $33Bn to insurers in the US & EU. The Venari Medical technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers.

CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world. The company seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound which is owned by the company. Its devices reduce healthcare costs and improve safety, quality, patient experience, and access to services around the globe. Invented by Dr. Tropello, CoapTech delivers a novel platform technology combining magnetic attraction for device placement guidance, and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional, and therapeutic procedures. Strong rare-earth magnets are used to manually guide devices placed inside the human body, while real-time, low-cost ultrasound provides visual feedback to the clinician to ensure safety. This platform technology, invented by the company founder, has the potential to disrupt multiple medical procedures, substantially reducing costs while improving safety and patient experience. Their lead use case, selected because of its low risk, clear FDA pathway, and strong commercial viability, is for the insertion of gastrostomy tubes. They have defined the use of Coaptive Ultrasound to perform this novel gastrostomy procedure, as Percutaneous Ultrasound Gastrostomy (PUG). Briefly, PUG is a point-of-care (as opposed to the operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers. It employs readily available medical devices such as ultrasound, feeding tubes, guide wires, and dilators.

ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise has created the base for the Trammpolin design and the development towards a prototype.

The company provides digital health software and hardware intended to offer proprietary insights into the pulmonary vasculature non-invasively and the product pipeline aims to address both at-home monitoring and critical care applications in categories such as heart failure and hemodynamics.

HD Medical provides visualize heart sounds, visualization of cardiac waveforms, detection, and management of cardio vascular disease. Additionally, they also provide patient diagnosis and treatment services.

Embolx is a venture-backed start-up in Silicon Valley that is developing and commercializing unique catheter-based systems that enable a breakthrough in minimally invasive localized cancer therapy. Embolx devices use pressure regulation to eliminate non-target delivery and increase drug distribution in the tumor using an advanced method known as Low Pressure Embolization (LPE).

At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.

toSense, Inc. develops CoVa Monitoring System, a body-worn sensor for patients at home with chronic illnesses, such as congestive heart failure, chronic obstructive pulmonary disease, hypertension, and renal failure. Its sensor remotely monitors thoracic impedance, heart rate, heart rate variability, respiration rate, skin temperature, and posture. The company also offers gateways that collect the data gathered by the sensor and forward it to a Web-based system for monitoring the patient’s health. toSense, Inc. was formerly known as Perminova, Inc. toSense, Inc. was incorporated in 2008 and is based in San Diego, California. As of March 31, 2020, toSense, Inc. operates as a subsidiary of Baxter International Inc.

Bone Health Technologies is a Redwood City-based health-tech company developing innovative, non-invasive, and science-backed solutions for people with low bone density. Its flagship product, Osteoboost, is an FDA-cleared wearable medical device clinically proven to significantly slow the loss of bone density and bone strength through patented precision vibration therapy in postmenopausal women with osteopenia. Inspired by NASA-funded research and driven by science and a commitment to improving health outcomes, Osteoboost is poised to become the new standard of care – offering a convenient, non-pharmacological, pain-free treatment to the nearly 64 million Americans at risk of osteoporotic fractures.

ClearCam provides clinicians with innovative tools and technologies that improve their vision and skill in the operating room. ClearCam was founded in 2018 and is headquartered in Austin, Texas.

Orbit Genomics technology platform enables early disease detection, treatment, and prevention of complex diseases. The platform analyzes repetitive DNA which uniquely reflects both inherited and acquired disease risk. They provides technology platform analyzes a different part of your DNA that uniquely reflects both inherited predisposition to disease.

Our founding team consists of highly experienced engineers with a strong record of successful technical projects from inception through production. As a founding principle, we have decided to apply the lessons and talents acquired after many decades to accomplish Evergaze's highly humanistic mission. Even though much of our technical knowledge is derived from the commercial, industrial and defense industries, it is all coming together to achieve this technologically breakthrough product that would not otherwise be possible. seeBoost® is the result of extensive consultation with a variety of stakeholders in low vision, including patients, practitioners, and researchers.

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy.

EndObetes is a medical device company that develops an endoscopically food delivery solution for treating obesity and diabetes. The company's device shunts food directly from the esophagus to the intestine, bypassing the stomach and duodenum, much like gastric bypass surgery, enabling people to get access to a durable, safe and effective non-surgical treatment for obesity and diabetes. It was founded in 2015 and is based in New York, New York.

ThermopeutiX offers imaginative, innovative, and economical solutions. They provide therapeutic solutions for vascular-related disorders and other issues.

Pristine Surgical has developed a first-of-its-kind, single-use visualization platform for surgical and diagnostic rigid endoscopic procedures by combining state-of-the-art, high-definition digital imaging with advanced LED lighting, artificial intelligence and cloud-based software. Its single-use arthroscopes and laparoscopes are delivered in a 100% sterile kit, and together with its cloud-based workflow reduction software, promises to reduce cost, reduce risk and increase efficiency for over 23 million procedures per year.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

Avisi Technologies develops VisiPlate, a next-generation, nanotechnology-enabled aqueous shunt intended to treat glaucoma.

Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow. The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant to facilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers. Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.

AMT Surgical distributes electrosurgical accessories. They focus on providing their customers with surgical solutions that optimize patient safety, clinical performance, ease of use, and cost-effectiveness. Their products include patient surgical plum, positioning, and electrosurgical accessories.

Auctus Surgical is developing a dynamic Vertebral Body tethering system for the treatment of pediatric scoliosis. The Auctus system is a non-fusion, endoscopic system allowing for non-surgical adjustment over time. Auctus has also licensed technology relating to magnetically adjustable growing rods for use in pediatric scoliosis and limb lengthening. Auctus believes that children with scoliosis should not be limited and deserve the same active healthy life as their peers without scoliosis.

EPIC Neuro is developing a small, leadless, minimally invasive device that provides brain stimulation and cortical EEG recording for stroke.

May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide patients with a more natural and less medicalised pregnancy experience. May Health aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. May Health's procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.

Conavi Medical is a technique for visualizing the intracardiac and intravascular systems that is intended to direct minimally invasive procedures. The company's technology makes use of a catheter-based ultrasound system that can produce 2-D and 3-D ultrasound images of cardiac anatomy all the way around the catheter's tip, allowing medical professionals to perform cardiovascular procedures like ablations that might need access to specific areas of the heart.

ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. ZetaGen Therapeutics's goal is to halt cancer, reduce pain, and rebuild bones. The company's solution has the potential to revolutionize the treatment of bone-related injuries, operations, and diseases, resulting in better outcomes for both patients and doctors.

Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.

Ictero Medical is a medical device company that provides minimally invasive gallbladder ablation solutions.

Deneb Medical is a start-up dedicated to developing a robotic platform for applications in neurosurgery, CMF surgery, head and neck surgery, urology and general surgery.

Tasso is revolutionizing blood-based diagnostics by placing the user at the center of the diagnostics process. Patients are able to sample their own blood in the comfort of their home with a device that is safe, simple, and convenient.

ODS Medical Inc. is a medical device company that seeks to commercialize their exclusive Raman spectroscopy system for real-time detection of tissue abnormalities through the development, manufacture and sales of products for a range of clinical settings. ODS Medical Inc. is dedicated to bringing to the hands of physicians the next generation of diagnostic tools. Building on our revolutionary proprietary platform technology, we integrate cutting edge optical probes with the most sophisticated software, based on machine learning algorithms, to empower doctors to make critical decisions- in real-time - with unprecedented sensitivity, specificity and accuracy.

Soundbite Medical Solutions is a medical device company developing products in the field of vessel preparation for management and treatment. The company developing and commercializing a proprietary wire-based device and generator console that delivers safe shockwave energy within the cardiovascular system to treat chronic total occlusions (CTO's). It will target CTO’s in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million, and 8 million Americans, respectively. Founded in 2013 and is based in Montréal, Quebec, Canada.

Paragate Medical provides device based solution for treating fluid overload in heart and kidney failure.

Sana Health is an audio-visual neuromodulation device, that provides anxiety relief on-demand - multiple applications in pain and mental health, 2 pivotal studies are underway in Fibromyalgia (FDA designated breakthrough device) and Neuropathic Pain. Anxiety and PTSD trials starting in Q2 2022, DoD grant for PTSD. SOSV, Founders Fund, Noetic Fund, Harmonix, Dreamit, Esplanade, Bridge Builders Collective, Menlo Ventures.

PercuSense provides a continuous multi-analyte sensor system that combines monitoring of multiple biosensors with knowledge of how diseases and illnesses progress to intelligently and proactively recommend treatment. With their ability to measure a diversity of analytes, they can be tailored for heart failure, cancer detection, and a variety of other applications.

Spire Health specializes in continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring. Its mission is to harness the power of algorithms and sensors to improve health outcomes by empowering patients and physicians with useful and actionable data.

AuriGen Medical is a structural heart and EP company, developing the first entirely trans-septal implant to treat both the stroke and arrhythmia risk associated with persistent atrial fibrillation.Treating patients with medication resistant long standing atrial fibrillation (AF) is expensive, time consuming and in the majority of cases ineffective. The incidence of this arrhythmia is rising rapidly as western populations age, urgently necessitating better treatment options. The target market for AuriGen’s technology are the highly symptomatic medication resistant AF patients, of which there are over 3 million in US and the EU combined, having 500,000 ablations per year. The costs associated with managing this group are in the billions of dollars and continue to escalate as the populations of developed countries get older.